IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ACBM

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.010.02--------
Accounts Receivable--------------------0.000.000.500.61--0.280.30------
Inventory------------------------------0.300.30--0.000.45
Total Current Assets0.000.000.010.000.040.000.010.000.000.000.000.010.530.640.660.610.630.680.710.62
Total Non-current Assets*0.000.000.000.000.010.020.030.040.040.050.060.010.010.020.030.040.040.050.050.01
Total Assets0.000.000.010.000.050.030.030.040.050.050.060.020.540.660.690.640.670.730.760.63
Accounts Payable0.060.060.060.120.100.140.150.160.150.150.150.150.090.130.080.020.020.000.030.02
Total Current Liabilities0.450.430.400.440.370.330.330.320.310.300.290.260.200.250.200.140.080.070.090.06
Total Non-current Liabilities*0.000.000.000.000.000.000.000.010.010.020.030.000.000.000.000.010.010.020.030.00
Total Liabilities*0.450.430.400.440.370.330.330.320.320.320.320.260.200.250.200.150.090.090.120.06
Retained Earnings(32.82)(32.80)(32.76)(32.80)(32.68)(32.67)(32.66)(32.65)(32.64)(32.63)(32.62)(32.60)(31.01)(27.81)(23.81)(19.87)(15.86)(11.87)(7.94)(4.08)
Total Stockholder Equity(0.44)(0.43)(0.39)(0.43)(0.32)(0.30)(0.29)(0.29)(0.28)(0.27)(0.26)(0.24)0.340.410.490.490.570.640.640.57
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.360.000.000.300.600.00
Cost of Revenue--------------------0.000.000.000.000.300.000.000.220.450.00
Gross Profit--------------------0.000.000.000.000.060.000.000.080.150.00
Research & Development------------0.000.000.000.000.000.401.882.522.522.522.52----2.12
Selling, General & Admin0.020.060.020.120.010.010.010.010.010.010.020.701.321.481.481.491.481.491.480.87
Total Operating Expenses0.020.060.020.120.010.010.010.010.010.010.021.593.194.004.004.014.004.014.002.99
Operating Income(0.02)(0.06)(0.02)(0.12)(0.01)(0.01)(0.01)(0.01)(0.01)(0.01)(0.02)(1.59)(3.19)(4.00)(3.93)(4.01)(4.00)(3.93)(3.85)(2.99)
Interest Expense------------------------------------0.000.00
Pretax Income----0.04(0.12)(0.02)(0.01)(0.01)(0.01)(0.01)(0.01)(0.02)(1.59)(3.20)(4.00)--(4.01)(4.00)------
Tax Provision----0.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00--0.000.00
Net Income(0.02)(0.04)0.04(0.12)(0.02)(0.01)(0.01)(0.01)(0.01)(0.01)(0.02)(1.59)(3.20)(4.00)(3.93)(4.01)(4.00)(3.93)(3.85)(2.99)
Diluted EPS0.000.000.000.000.000.000.000.000.000.000.00(0.03)----------------
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(10.50)(49.82)(25.38)(54.41)(93.98)(22.53)(10.51)(6.33)(6.33)(13.51)(12.61)0.482.25(5.57)(10.57)(53.27)(345.78)262.13(60.51)(64.55)
Financing Cash Flow10.2849.6025.1558.7193.7622.3110.296.117.1013.299.720.110.110.040.2357.350.220.291.093.72
← Scroll for more columns →